Skip to main content
Clinical Trials/NCT04473898
NCT04473898
Completed
Not Applicable

Telerehabilitation After Covid-19: Effectiveness of Respiratory and Aerobic Training

KTO Karatay University1 site in 1 country35 target enrollmentJune 19, 2020
ConditionsCOVID

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID
Sponsor
KTO Karatay University
Enrollment
35
Locations
1
Primary Endpoint
Health Related Quality of Life
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of the study is to investigate the effects of telerehabilitation program on COVID-19 symptoms, quality of life, level of depression, perception of dyspnea, sleep, fatigue, kinesiophobia and patient satisfaction in individuals diagnosed with COVID-19.

Detailed Description

Because of the risk of infection, telerehabilitation applications are recommended for patients with COVID-19. There are no studies in the literature evaluating the effectiveness of telerehabilitation program after COVID-19. In particular, the importance of the first eight weeks after the disease was emphasized. It is thought that the telerehabilitation program will improve the functional capacities and quality of life of patients in order to adapt to the daily life after the infection more easily, to cope with the symptoms brought about by the disease more easily and to prevent the respiratory distress, intensive care stay and inactivity due to muscle weakness.

Registry
clinicaltrials.gov
Start Date
June 19, 2020
End Date
February 17, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
KTO Karatay University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • volunteering to participate in the study
  • at least once diagnosed with COVID-19,
  • has a cognitive level that can adapt to online exercises,
  • having a physical condition suitable for exercises
  • staying in hospital due to covid-19

Exclusion Criteria

  • refuse to participate in the study
  • having neurological, cardiac, respiratory disease that prevents exercise

Outcomes

Primary Outcomes

Health Related Quality of Life

Time Frame: 6 weeks later

It will be evaluated by SF-36

Sleep Quality

Time Frame: 6 weeks later

It will be evaluated by pittsburgh sleep quality index

Dyspnoea

Time Frame: 6 weeks later

It will be evaluated by the Modified Medical Research Council (mMRC). It will be evaluated by the Modified Medical Research Council (mMRC). It consists of 5 items between 0 and 4. The increase in the score indicates the severity of dyspnea.

Anxiety and Depression

Time Frame: 6 weeks later

It will be evaluated by the Hospital Anxiety and Depression Scale (HADS). The questionnaire comprises seven questions for anxiety and seven questions for depression, and takes 2-5min to complete. Although the anxiety and depression questions are interspersed within the questionnaire, it is vital that these are scored separately. Cut-off scores are available for quantification, for example a score of 8 or more for anxiety. The increase in the score indicates the severity of anxiety and depression.

Secondary Outcomes

  • Kinesiophobia(6 weeks later)
  • Patient Satisfaction(6 weeks later)
  • Fatigue(6 weeks later)

Study Sites (1)

Loading locations...

Similar Trials